Thiamethoxam


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
11199 ANXA10 Increases expression PMID:32194361
1557 CYP2C19 Decreases expression PMID:32194361
1581 CYP7A1 Decreases expression PMID:32194361
1583 CYP11A1 Decreases expression PMID:34181816
1586 CYP17A1 Decreases expression PMID:34181816
1588 CYP19A1 Increases activity PMID:26464060; PMID:28750898
1588 CYP19A1 Increases expression PMID:26464060; PMID:34181816
1649 DDIT3 Increases expression PMID:33533595
2099 ESR1 Decreases expression PMID:33533595
2309 FOXO3 Increases expression PMID:33533595
23657 SLC7A11 Increases expression PMID:33533595
249 ALPL Increases activity PMID:30621503
2492 FSHR Decreases expression PMID:33533595
2538 G6PC1 Decreases expression PMID:32194361
2805 GOT1 Increases activity PMID:30621503
2875 GPT Decreases activity PMID:29197058
2876 GPX1 Affects expression PMID:33533595; PMID:36958429
2876 GPX1 Decreases activity PMID:30621503
3283 HSD3B1 Decreases expression PMID:34181816
3309 HSPA5 Increases expression PMID:33533595
3553 IL1B Increases expression PMID:36958429
3569 IL6 Increases expression PMID:36958429
3708 ITPR1 Decreases expression PMID:33533595
3726 JUNB Decreases expression PMID:33533595
383 ARG1 Decreases expression PMID:32194361
3939 LDHA Increases activity PMID:30621503
3973 LHCGR Affects expression PMID:33533595; PMID:34181816
4160 MC4R Decreases expression PMID:33533595
4316 MMP7 Increases expression PMID:33533595
4616 GADD45B Decreases expression PMID:33533595
467 ATF3 Increases expression PMID:33533595
4843 NOS2 Decreases activity PMID:29197058
4843 NOS2 Increases expression PMID:36958429
5336 PLCG2 Decreases expression PMID:33533595
5621 PRNP Increases expression PMID:33533595
5743 PTGS2 Decreases expression PMID:33533595
5744 PTHLH Decreases expression PMID:33533595
5806 PTX3 Increases expression PMID:33533595
581 BAX Increases expression PMID:33533595
596 BCL2 Decreases expression PMID:33533595
604 BCL6 Decreases expression PMID:33533595
6286 S100P Increases expression PMID:32194361
6347 CCL2 Increases expression PMID:33533595
6374 CXCL5 Increases expression PMID:33533595
6582 SLC22A2 Decreases activity PMID:31364238
6647 SOD1 Decreases activity PMID:30621503
6647 SOD1 Decreases expression PMID:36958429
6770 STAR Decreases expression PMID:34181816
694 BTG1 Increases expression PMID:33533595
7060 THBS4 Decreases expression PMID:33533595
7124 TNF Increases expression PMID:36958429
7940 LST1 Increases expression PMID:33533595
83667 SESN2 Increases expression PMID:33533595
847 CAT Affects expression PMID:33533595; PMID:36958429
847 CAT Decreases activity PMID:30621503; PMID:34181816; PMID:36958429
8614 STC2 Increases expression PMID:33533595
949 SCARB1 Decreases expression PMID:34181816

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.